Vagelos P Roy
- SEC CIK
- 0001013064
No open-market purchases or sales filed in the past year.
Current role at each company
- REGN Regeneron Pharmaceuticals, Inc.Directoras of Apr 5, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Vagelos P Roy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 (view filing) | Mar 30 | 2 days | Vagelos P RoyDirector | SSale | −28.6K | $700.01 | −$20.0M | −54.9%23.5K after | 2 lots |
| Aug 19, 2021 (view filing) | Aug 18 | 1 day | Vagelos P RoyDirector | SSale | −10.0K | $650.04 | −$6.53M | −21.0%37.7K after |